2,3-Dimethyl-1,6-Naphthyridin | 50346-05-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 2,3-Dimethyl-1,6-Naphthyridin
• 英文别名: 2,3-dimethyl-[1,6]naphthyridine；2,3-Dimethyl-1,6-naphthyridine
• CAS: 50346-05-9
• 化学式: C₁₀H₁₀N₂
• mdl: MFCD18802758
• 分子量: 158.203
• InChiKey: WAEYKNPYYAGOCA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] METHODS AND INTERMEDIATES FOR THE PREPARATION OF MACROLACTAMS<br/>[FR] PROCÉDÉS ET INTERMÉDIAIRES POUR LA PRÉPARATION DE MACROLACTAMES
  申请人：MERCK SHARP & DOHME

  公开号：WO2015095430A1

  公开（公告）日：2015-06-25

  The present invention relates to synthetic processes useful in the preparation of macrolactams that inhibit hepatitis C virus (HCV), specifically macrolactam compounds that inhibit the HCV NS3 protease activity and have application in the treatment of conditions caused by HCV. The present invention also encompasses intermediates useful in the disclosed synthetic processes and the methods of their preparation.

  本发明涉及在制备抑制丙型肝炎病毒（HCV）的大环内酰胺类化合物中有用的合成工艺，特别是抑制HCV NS3蛋白酶活性并可用于治疗由HCV引起的病症的大环内酰胺化合物。本发明还包括在所述合成工艺中有用的中间体及其制备方法。
• Inhibitors of Akt Activity
  申请人：Bilodeau Mark T.

  公开号：US20080280899A1

  公开（公告）日：2008-11-13

  The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.

  本发明涉及含有取代萘啶的化合物，其抑制Akt，一种丝氨酸/苏氨酸蛋白激酶的活性。本发明还涉及包含该发明化合物的化疗组合物以及使用该发明化合物治疗癌症的方法。
• ORGANIC LIGHT-EMITTING DEVICE
  申请人：Samsung Display Co., Ltd.

  公开号：US20160351817A1

  公开（公告）日：2016-12-01

  An organic light-emitting device including a first electrode, a second electrode, and an organic layer between the first electrode and the second electrode and including an emission layer. The organic layer may include a first compound represented by Formula 1 and a second compound represented by Formula 2: When the first compound represented by Formula 1 and the second compound represented by Formula 2 are included in the emission layer, the organic light-emitting device may have improved (e.g. increased) efficiency and lifespan characteristics.
• US7750151B2
  申请人：——

  公开号：US7750151B2

  公开（公告）日：2010-07-06